Khoo, Joan

Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non‐alcoholic fatty liver disease

Khoo, J., Hsiang, J. C., Taneja, R., Koo, S., Soon, G., Kam, C. J., Law, N., & Ang, T. (2019) · Liver International

Liver Disease Diagnosis and TreatmentBariatric Surgery and Outcomes

Cited by 136

Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes

Young, R. L., Chia, B., Isaacs, N. J., Ma, J., Khoo, J., Wu, T., Horowitz, M., & Rayner, C. K. (2013) · Diabetes

Biochemical Analysis and Sensing TechniquesDiabetes Treatment and Management

Cited by 111

Comparing effects of low- and high-volume moderate-intensity exercise on sexual function and testosterone in obese men

Khoo, J., Tian, H.-H., Tan, B., Chew, K., Ng, C.-S., Leong, D., Teo, R. C.-C., & Chen, R. Y.-T. (2013) · The Journal of Sexual Medicine

Sexual function and dysfunction studiesHormonal and reproductive studies

Cited by 101

Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: a pilot randomized trial

Khoo, J., Hsiang, J., Taneja, R., Law, N., & Ang, T. (2017) · Diabetes Obesity and Metabolism

Liver Disease Diagnosis and TreatmentPharmacology and Obesity Treatment

Cited by 99

The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: A randomized controlled trial

Thazhath, S. S., Marathe, C. S., Wu, T., Chang, J., Khoo, J., Kuo, P., Checklin, H. L., Bound, M. J., Rigda, R. S., Crouch, B., et al. (2016) · Diabetes

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 83